Suven Pharmaceuticals Q3 Results

  • BSE: 543064
  • NSE: SUVENPHAR
  • ISIN: INE03QK01018
  • Sector: Biotechnology & Drugs
BSE
1,275.05-19.30 (-1.49%)
Volume18.75 K
Updated: Mon 25 Nov, 2024 | 15:29:44
NSE
1,293.9-1.25 (-0.10%)
Volume4.21 L
Updated: Mon 25 Nov, 2024 | 15:31:16
Today: 1,270.80
1,333.65
52-Wk: 578.05
1,358.75

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Suven Pharmaceuticals Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 219.82231.05-%353.77-%
    Selling/ General/ Admin Expenses Total 32.8328.58-%29.68-%
    Depreciation/ Amortization 12.7511.89-%12.24-%
    Other Operating Expenses Total 14.4213.16-%18.13-%
    Total Operating Expense 167.43144.98-%219.32-%
    Operating Income 52.3986.07-%134.46-%
    Net Income Before Taxes 65.47105.41-%146.08-%
    Net Income 46.7579.56-%107.72-%
    Diluted Normalized EPS 1.843.13-%4.23-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts